We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
-2.18%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$13.1B
AUM Growth
+$754M
(+6.1%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
8.89%
Top 10 Holdings %
Top 10 Hldgs %
38.02%
Holding
1,188
New
182
Increased
340
Reduced
340
Closed
221
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$379M |
| 2 |
NVIDIA
NVDA
|
+$323M |
| 3 |
Amazon
AMZN
|
+$133M |
| 4 |
UnitedHealth
UNH
|
+$97.5M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$86.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$89.2M |
| 2 |
ExxonMobil
XOM
|
+$83.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$83.1M |
| 4 |
CVS Health
CVS
|
+$82.2M |
| 5 |
Eli Lilly
LLY
|
+$66.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Healthcare | 11.42% |
| 3 | Energy | 7.9% |
| 4 | Consumer Discretionary | 6.67% |
| 5 | Financials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DSL
551
DoubleLine Income Solutions Fund
DSL
$1.21B
| $676K | 0.01% |
57,719
-3,762
| -6% | -$45K |
|
552
Trip.com Group
TCOM
$27.5B
| $673K | 0.01% |
19,254
-3,012
| -14% | -$113K |
|
|
NVRO
553
DELISTED
NEVRO CORP.
NVRO
| $663K | 0.01% |
34,500
+7,500
| +28% | +$160K |
|
554
Pacira BioSciences
PCRX
$1.02B
| $660K | 0.01% |
21,500
+6,000
| +39% | +$216K |
|
555
Assurant
AIZ
$13.7B
| $657K | 0.01% |
4,576
-23,670
| -84% | -$3.24M |
|
556
Pembina Pipeline
PBA
$29.9B
| $655K | 0.01% |
21,738
-100,341
| -82% | -$3.09M |
|
557
Camden Property Trust
CPT
$11.3B
| $648K | 0.01% |
6,849
-50,633
| -88% | -$5.38M |
|
558
O'Reilly Automotive
ORLY
$72.4B
| $647K | 0.01% |
10,680
-130,620
| -92% | -$8.19M |
|
559
APA Corp
APA
$12.8B
| $647K | 0.01% |
15,744
+677
| +4% | +$27.9K |
|
|
SAGE
560
DELISTED
Sage Therapeutics
SAGE
| $638K | ﹤0.01% |
+31,000
| New | +$895K |
|
561
Post Holdings
POST
$4.12B
| $638K | ﹤0.01% |
+7,439
| New | +$649K |
|
562
Loews
L
$24.3B
| $626K | ﹤0.01% |
9,891
+429
| +5% | +$26.7K |
|
563
Henry Schein
HSIC
$9.74B
| $624K | ﹤0.01% |
8,403
+313
| +4% | +$24.1K |
|
564
Outset Medical
OM
$74.9M
| $615K | ﹤0.01% |
3,768
-598
| -14% | -$141K |
|
565
FedEx
FDX
$74.5B
| $612K | ﹤0.01% |
2,311
+820
| +55% | +$213K |
|
|
THRN
566
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $611K | ﹤0.01% |
+60,000
| New | +$457K |
|
567
Gen Digital
GEN
$15.6B
| $605K | ﹤0.01% |
34,229
-6,100
| -15% | -$119K |
|
|
BCTX
568
Briacell Therapeutics
BCTX
$31.1M
| $597K | ﹤0.01% |
637
+35
| +6% | +$34.3K |
|
569
PPG Industries
PPG
$25.9B
| $589K | ﹤0.01% |
4,535
+891
| +24% | +$125K |
|
570
Teleflex
TFX
$5.85B
| $588K | ﹤0.01% |
2,993
+129
| +5% | +$29.3K |
|
571
Broadstone Net Lease
BNL
$4.29B
| $588K | ﹤0.01% |
+41,088
| New | +$658K |
|
|
JNPR
572
DELISTED
Juniper Networks
JNPR
| $584K | ﹤0.01% |
21,024
-181,689
| -90% | -$5.23M |
|
573
Super Micro Computer
SMCI
$19.5B
| $583K | ﹤0.01% |
+21,270
| New | +$593K |
|
574
TC Energy
TRP
$73.5B
| $579K | ﹤0.01% |
16,792
-2,937
| -15% | -$108K |
|
|
EMAN
575
DELISTED
eMagin Corporation
EMAN
| $574K | ﹤0.01% |
289,785
+110,000
| +61% | +$218K |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q3 2023 Portfolio in Review
As of Q3 2023, Natixis held 1,188 positions worth $13.1B, up 6.1% from $12.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Natixis deployed $1.16B of net new capital in Q3 2023, opening 182 new positions and adding to 340 existing holdings. Its largest new stake was Oneok: 965,015 shares worth $61.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 21% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $89.2M trimmed.
- Natixis's largest Q3 2023 buy was Oneok: 965,015 shares worth $61.2M.
- Natixis added most to Apple in Q3 2023, an estimated $379M increase.
- Natixis's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $89.2M.
- Natixis fully exited Bristol-Myers Squibb in Q3 2023, selling an estimated $83.1M.
- Natixis's ten largest holdings make up 38% of its $13.1B portfolio in Q3 2023.
- Natixis opened 182 new positions and closed 221 in Q3 2023.
- Natixis's portfolio value rose 6.1% quarter-over-quarter to $13.1B.
Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.